Six-month outcomes from the first-in-human, single-arm SELUTION Sustained-Limus-Release Drug-Eluting Balloon trial in femoropopliteal lesions - Zeller, T; Brechtel, K; Meyer, D R (J Endovasc Ther, 2020)
et al.